Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.20    -0.20 (-0.23%)
Bid:
85.50
Ask:
88.00
Spread: 2.50 (2.924%)
Market Cap: £366.55m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

GPB26m investment

13 Mar 2007 07:01

PZ CUSSONS PLC13 March 2007 PRESS RELEASE 13 March 2007 PZ CUSSONS PLC £26M INVESTMENT IN MANUFACTURING AND R&D CENTRE IN MANCHESTER PZ Cussons Plc (LSE: PZC.L) is pleased to announce that in response to the rapidgrowth of its UK business, it is investing £26 million in a new, purpose-builtInnovation Centre in Agecroft, Greater Manchester. The site has recently beenpurchased from the North West Development Agency, and construction is under way,with planned completion in 2009. The Innovation Centre will comprise: • a new high speed Liquids Factory, significantly increasing capacity for themanufacture of the Group's UK liquid product ranges. The new factory isexpected to produce around 150 million units per year, an increase of some 50%above current capacity levels; • a new Research & Development Centre, creating an international centre ofexcellence, with a 25-strong team of chemists working on site in a state of theart facility to create new formulations; • a new Fragrance Development Centre, which will create and producesophisticated perfumes for the UK business and the wider Group. PZ Cussons is number one in the personal wash category in the UK, with theImperial Leather, Carex and Original Source brands, and number two in thedesigner hair care category with the Charles Worthington brand. This investment recognises the continuing importance of the UK market, and re-affirms theGroup's commitment to developing leading brands and product ranges within themarket for which they are intended, to better meet consumer requirements and tastes. Alternative locations for the centre were considered, including Eastern Europeand the Far East. However locating the facility in Manchester allows PZ Cussonsto continue to provide reliability of supply chain and speed to market for its UK retail customers. Importantly, it also allows the Group to retain its highlyskilled workforce, as well as accessing the academic research of the localManchester universities. Furthermore, the facility will enable close involvementwith the UK sales and marketing team. As well as serving the UK, the R&Dcapability of the Innovation Centre will also be able to support the productdevelopment work of the wider PZ Cussons group. There will be approximately 150 people employed at the site, the vast majorityof whom will be transferred from the existing facilities in Kersal Vale,Stockport and Ellesmere Port which will be closed. No compulsory redundanciesare planned at these sites in relation to the move. Graham Calder, Deputy Chairman, said: "Having carried out a thorough analysis of all the options open to us, it isclear that further investment in our presence in the North West of England isthe right decision both for the business and for our customers. "The development of a UK centre of excellence reflects our strategy of buildingbusinesses in selected markets that have the ability to understand and respondto their particular needs. "Our UK business has been expanding rapidly and, in recent years, we have madegreat strides in product innovation for the UK market, with innovation in theImperial Leather range with Foamburst Shower, a complete overhaul of theOriginal Source Range and the recent launch of the Charles Worthington Men'sand Style.com ranges. This investment will provide the foundations for furtherlong term growth." -Ends-Enquiries: PZ Cussons Plc Tel: 0161 491 8000Graham Calder/ Brandon Leigh / Chris How Hogarth Partnership Limited Tel: 020 7357 9477John Olsen / Sarah MacLeod / Sarah Richardson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.